FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023922443> ?p ?o ?g. }

• W2023922443 endingPage "1632" @default.
• W2023922443 startingPage "1616" @default.
• W2023922443 abstract "Idiosyncratic adverse drug reactions (IADRs) in humans can result in a broad range of clinically significant toxicities leading to attrition during drug development as well as postlicensing withdrawal or labeling. IADRs arise from both drug and patient related mechanisms and risk factors. Drug related risk factors, resulting from parent compound or metabolites, may involve multiple contributory mechanisms including organelle toxicity, effects related to compound disposition, and/or immune activation. In the current study, we evaluate an in vitro approach, which explored both cellular effects and covalent binding (CVB) to assess IADR risks for drug candidates using 36 drugs which caused different patterns and severities of IADRs in humans. The cellular effects were tested in an in vitro Panel of five assays which quantified (1) toxicity to THLE cells (SV40 T-antigen-immortalized human liver epithelial cells), which do not express P450s, (2) toxicity to a THLE cell line which selectively expresses P450 3A4, (3) cytotoxicity in HepG2 cells in glucose and galactose media, which is indicative of mitochondrial injury, (4) inhibition of the human bile salt export pump, BSEP, and (5) inhibition of the rat multidrug resistance associated protein 2, Mrp2. In addition, the CVB Burden was estimated by determining the CVB of radiolabeled compound to human hepatocytes and factoring in both the maximum prescribed daily dose and the fraction of metabolism leading to CVB. Combining the aggregated results from the in vitro Panel assays with the CVB Burden data discriminated, with high specificity (78%) and sensitivity (100%), between 27 drugs, which had severe or marked IADR concern, and 9 drugs, which had low IADR concern, we propose that this integrated approach has the potential to enable selection of drug candidates with reduced propensity to cause IADRs in humans." @default.
• W2023922443 created "2016-06-24" @default.
• W2023922443 creator A5003537475 @default.
• W2023922443 creator A5004631499 @default.
• W2023922443 creator A5009006783 @default.
• W2023922443 creator A5015186372 @default.
• W2023922443 creator A5018882841 @default.
• W2023922443 creator A5028281331 @default.
• W2023922443 creator A5029689967 @default.
• W2023922443 creator A5051498699 @default.
• W2023922443 creator A5061761689 @default.
• W2023922443 creator A5063126822 @default.
• W2023922443 creator A5063846712 @default.
• W2023922443 creator A5067227661 @default.
• W2023922443 creator A5090489465 @default.
• W2023922443 date "2012-05-31" @default.
• W2023922443 modified "2023-10-05" @default.
• W2023922443 title "In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs" @default.
• W2023922443 cites W1527821398 @default.
• W2023922443 cites W1958573926 @default.
• W2023922443 cites W1964251823 @default.
• W2023922443 cites W1968687693 @default.
• W2023922443 cites W1969780974 @default.
• W2023922443 cites W1970513035 @default.
• W2023922443 cites W1971698096 @default.
• W2023922443 cites W1977122152 @default.
• W2023922443 cites W1979893692 @default.
• W2023922443 cites W1983060510 @default.
• W2023922443 cites W1987144475 @default.
• W2023922443 cites W1989343195 @default.
• W2023922443 cites W1990355599 @default.
• W2023922443 cites W1996935441 @default.
• W2023922443 cites W1998101020 @default.
• W2023922443 cites W1999587831 @default.
• W2023922443 cites W2000692862 @default.
• W2023922443 cites W2002915215 @default.
• W2023922443 cites W2003181581 @default.
• W2023922443 cites W2006991577 @default.
• W2023922443 cites W2022868257 @default.
• W2023922443 cites W2023963798 @default.
• W2023922443 cites W2024941157 @default.
• W2023922443 cites W2027710934 @default.
• W2023922443 cites W2030920368 @default.
• W2023922443 cites W2031012648 @default.
• W2023922443 cites W2050007442 @default.
• W2023922443 cites W2052382555 @default.
• W2023922443 cites W2055409375 @default.
• W2023922443 cites W2060832204 @default.
• W2023922443 cites W2064798207 @default.
• W2023922443 cites W2064889561 @default.
• W2023922443 cites W2065108839 @default.
• W2023922443 cites W2073882671 @default.
• W2023922443 cites W2074577842 @default.
• W2023922443 cites W2075221169 @default.
• W2023922443 cites W2077796674 @default.
• W2023922443 cites W2082507505 @default.
• W2023922443 cites W2083462224 @default.
• W2023922443 cites W2083503771 @default.
• W2023922443 cites W2097324008 @default.
• W2023922443 cites W2101016189 @default.
• W2023922443 cites W2110942596 @default.
• W2023922443 cites W2120398079 @default.
• W2023922443 cites W2123907272 @default.
• W2023922443 cites W2127284788 @default.
• W2023922443 cites W2134837921 @default.
• W2023922443 cites W2139008909 @default.
• W2023922443 cites W2140639850 @default.
• W2023922443 cites W2140772049 @default.
• W2023922443 cites W2142462614 @default.
• W2023922443 cites W2146316557 @default.
• W2023922443 cites W2147489083 @default.
• W2023922443 cites W2153972688 @default.
• W2023922443 cites W2159145664 @default.
• W2023922443 cites W2160736876 @default.
• W2023922443 cites W2164717015 @default.
• W2023922443 cites W2170675654 @default.
• W2023922443 cites W2325055018 @default.
• W2023922443 cites W3015642102 @default.
• W2023922443 cites W3189565531 @default.
• W2023922443 cites W4303093120 @default.
• W2023922443 cites W88754920 @default.
• W2023922443 cites W2074516036 @default.
• W2023922443 doi "https://doi.org/10.1021/tx300091x" @default.
• W2023922443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22646477" @default.
• W2023922443 hasPublicationYear "2012" @default.
• W2023922443 type Work @default.
• W2023922443 sameAs 2023922443 @default.
• W2023922443 citedByCount "187" @default.
• W2023922443 countsByYear W20239224432012 @default.
• W2023922443 countsByYear W20239224432013 @default.
• W2023922443 countsByYear W20239224432014 @default.
• W2023922443 countsByYear W20239224432015 @default.
• W2023922443 countsByYear W20239224432016 @default.
• W2023922443 countsByYear W20239224432017 @default.
• W2023922443 countsByYear W20239224432018 @default.
• W2023922443 countsByYear W20239224432019 @default.
• W2023922443 countsByYear W20239224432020 @default.
• W2023922443 countsByYear W20239224432021 @default.

• next